Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase NA 19Phase 1 15Phase 1/2 14Phase EARLY_PHASE1 5Phase 3 4Phase 2/3 4Phase 4 1

Status

Unknown 108Completed 92Recruiting 75Not yet recruiting 30Terminated 29Active not recruiting 22Withdrawn 15Suspended 4Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Carcinoma, Hepatocellular 2Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Liver Neoplasms 1

Interventions

lenvatinib 1Sorafenib 1Photochemotherapy 1Nivolumab 1NUC-1031 1Gemcitabine 1Folfox protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Suspended × Gastrointestinal × Clear all
NCT05033522 2025-10-23

ALIVE

Mirror Biologics, Inc.

Phase 2/3 Suspended
150 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04268888 2025-02-26

TACE-3

The Clatterbridge Cancer Centre NHS Foundation Trust

Phase 2/3 Suspended
522 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03610100 2019-10-29

ACELARATE

The Clatterbridge Cancer Centre NHS Foundation Trust

Phase 2/3 Suspended
328 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT01872104 2013-06-07

PDT-R-01

Central South University

Phase 2/3 Suspended
100 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡